Castle Creek Pharmaceuticals

查看带有其 10 名主要高管的组织结构图

Castle Creek Pharmaceuticals 搜索最多的简介

• Matthew Gantz, Chief Executive Officer
• Christopher Ballas, Chief Technology Officer
• Matthew Crabtree, Senior Director of Finance and Corporate Control...

创建提醒
跟踪 Castle Creek Pharmaceuticals 的高管变动

Castle Creek Pharmaceuticals 拥有 1,840 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。

Popular M&A news in 药店

• BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
• GlycoMimetics and Crescent Biopharma have announced they will merge  (公布2024十一月15号)..
• Grace Therapeutics将在Oct 25, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).

药店 行业的其他推荐联系人

• Sanofi 企业 Julie Van Ongevalle - Executive Vice President and Head of Consumer Healthcare
• Amneal Pharmaceuticals 企业 Paul Meister - Chairman of the Board
• Braeburn Pharmaceuticals 企业 Seth Harrison - Chairman and Director

了解更多有关药店行业的信息 >

Castle Creek Pharmaceuticals 的最新新闻稿

• Castle Creek Biosciences: News and Updates
• Castle Creek Biosciences: News and Updates
• Press Release Archives - Castle Creek Biosciences, Inc.
• Press Release Archives - Castle Creek Biosciences, Inc. : Castle Creek Biosciences, Inc.
• News, Events & Presentations - Castle Creek Biosciences, Inc. : Castle Creek Biosciences, Inc.
• Recent Press Releases Archives - Castle Creek Pharma
• View more press releases Close

关于 Castle Creek Pharmaceuticals 的社交媒体

• Castle Creek Pharmaceuticals 在 维基百科、谷歌新闻 和 雅虎财经
• Castle Creek Pharmaceuticals 在 LinkedIn、叽叽喳喳 和 YouTube

通过电子邮件联系联系该企业高管，包括 Matthew Gantz

致电Castle Creek Pharmaceuticals，电话：+1 973...

查看组织结构图

Register to receive your alert

报告错误